MARISSA QUEHL: Open Payments
NPI 1093466310 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$818 in 39 payments from 15 companies in 2025. Trend: 2023 $1,488 · 2024 $754 · 2025 $818
Food & beverage: $719Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 12 | $283 |
| Sumitomo Pharma America, Inc. | 2 | $78 |
| PFIZER INC. | 4 | $75 |
| Novo Nordisk Inc | 4 | $65 |
| Lilly USA, LLC | 4 | $63 |
| Exact Sciences Corporation | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| INOGEN, INC. | 1 | $24 |
Products named: Veozah, GEMTESA, PREVNAR 20, MOUNJARO, Wegovy, INSPIRE, Ozempic, OFEV.
Industry payments across TX — which companies pay providers there.
